XML 50 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details 2) (USD $)
12 Months Ended 0 Months Ended 12 Months Ended 0 Months Ended 1 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 33 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended
Dec. 31, 2013
Dec. 31, 2013
Service based restricted stock units
2012 Plan
Dec. 05, 2012
Service based restricted stock units
CEO
Dec. 31, 2013
Performance based restricted stock units
Mar. 20, 2013
Performance based restricted stock units
CEO
Dec. 05, 2012
Performance based restricted stock units
CEO
Dec. 31, 2013
Performance based restricted stock units
CEO
Dec. 31, 2013
Founder
Dec. 31, 2012
Founder
Dec. 31, 2011
Stock options
Dec. 31, 2013
Stock options
Dec. 31, 2012
Stock options
Dec. 31, 2013
Stock options
Dec. 31, 2013
Stock options
Minimum
Dec. 31, 2012
Stock options
Minimum
Dec. 31, 2011
Stock options
Minimum
Dec. 31, 2013
Stock options
Maximum
Dec. 31, 2012
Stock options
Maximum
Dec. 31, 2011
Stock options
Maximum
Dec. 31, 2011
Stock options
Employees
Dec. 31, 2013
Stock options
Employees
Dec. 31, 2012
Stock options
Employees
Dec. 31, 2011
Stock options
Non-employees
Dec. 31, 2013
Stock options
Non-employees
Dec. 31, 2012
Stock options
Non-employees
Dec. 31, 2011
Stock options
Non-employees
Dec. 31, 2013
Restricted stock units
Dec. 31, 2012
Restricted stock units
Dec. 05, 2012
Restricted stock units
CEO
Dec. 31, 2013
Restricted stock units
CEO
Sep. 30, 2013
Restricted stock units
CEO
Jun. 30, 2013
Restricted stock units
CEO
Mar. 31, 2013
Restricted stock units
CEO
Feb. 07, 2014
Restricted stock units
Performance based restricted stock units
Shares                                                                    
Unvested at the beginning of the period (in shares)               1,645,141 2,319,646                                                  
Granted (in shares)     128,205     64,103 32,051                                           192,308          
Vested (in shares)             (19,230) (658,060) (674,505)                                         (16,025) (16,025) (16,025) (16,025)  
Unvested at the end of the period (in shares)               987,081 1,645,141                                                  
Shares                                                                    
Outstanding at the beginning of the period (in shares)                     1,218,153                                              
Granted (in shares)                     1,537,172                   1,537,172 679,251     39,685 165,339                
Exercised (in shares)                     (42,799)                                              
Forfeited (in shares)                     (278,158)                                              
Cancelled (in shares)                     (21,131)                                              
Outstanding at the end of the period (in shares)                     2,413,237 1,218,153 2,413,237                                          
Exercisable at the end of the period (in shares)                     468,710   468,710                                          
Vested and expected to vest at the end of the period (in shares)                     1,445,760   1,445,760                                          
Weighted average exercise price per share                                                                    
Outstanding at the beginning of the period (in dollars per share)                     $ 3.83                                              
Granted (in dollars per share)                     $ 12.87                   $ 12.87 $ 6.59     $ 4.81 $ 0.04                
Exercised (in dollars per share)                     $ 0.99                                              
Forfeited (in dollars per share)                     $ 7.07                                              
Cancelled (in dollars per share)                     $ 4.01                                              
Outstanding at the end of period (in dollars per share)                     $ 9.26 $ 3.83 $ 9.26                                          
Exercisable at the end of the period (in dollars per share)                     $ 3.46   $ 3.46                                          
Vested and expected to vest at the end of the period (in dollars per share)                     $ 8.14   $ 8.14                                          
Weighted average remaining contractual term                                                                    
Outstanding at the beginning of the period                     9 years 18 days 9 years 4 months 2 days                                            
Outstanding at the end of the period                     9 years 18 days 9 years 4 months 2 days                                            
Exercisable at the end of the period                     8 years 3 months 11 days                                              
Vested and expected to vest at the end of the period                     8 years 10 months 24 days                                              
Aggregate intrinsic value                                                                    
Outstanding at the beginning of the period                     $ 5,535,000                                              
Outstanding at the end of period                     6,087,000 5,535,000 6,087,000                                          
Exercisable at the end of period                     3,112,000   3,112,000                                          
Vested and expected to vest at the end of the period                     4,192,000   4,192,000                                          
Total intrinsic value                   0 400,000 48,000 400,000                                          
Development stage product development revenues 0                                                                  
Assumptions used to estimate fair value of each stock-based option award on the grant date using the Black-Scholes option pricing model                                                                    
Risk free interest rate (as a percent)                           0.91% 0.80% 1.20% 2.11% 1.78% 1.84%                              
Volatility (as a percent)                           83.00% 79.00% 79.00% 91.00% 89.00% 82.00%                              
Expected term                           5 years 1 month 6 days 5 years 1 month 6 days 6 years 9 years 11 months 5 days 9 years 11 months 5 days 9 years 9 months                              
Additional disclosures                                                                    
Weighted average grant-date fair value of options granted (in dollars per share)                                         $ 9.34 $ 4.82                       $ 8.75
Granted (in dollars per share)     $ 7.80   $ 10.00                                                          
Vested in period fair value                                                     800,000              
Share-based compensation expense       0                               26,000 2,300,000 300,000 300,000 2,200,000 1,000,000   700,000 36,000            
Total unrecognized compensation cost, net of estimated forfeitures, related to unvested stock options and restricted stock units (in dollars) $ 8,800,000 $ 500,000                                                                
Weighted average period for recognition of compensation cost related to unvested stock awards 2 years 8 months 12 days 1 year